Gain an unbiased perspective of the market and its potential.

Market Dynamix™ reports blend data from specialists, patients, and leading KOLs.

• Market size and current treatment approaches
• What’s needed to support early adoption and optimization of an asset
• Unmet needs and attributes most desired in new therapeutics
• Expert opinions on the likely disruption introduced by pipeline agents

Methodology:

• Insights are based on analyses of quantitative data from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs

Sample Size & Frequency:

Gain an unbiased perspective of the market and its potential.

• Market size and current treatment approaches
• What’s needed to support early adoption and optimization of an asset
• Unmet needs and attributes most desired in new therapeutics
• Expert opinions on the likely disruption introduced by pipeline agents

• Insights are based on analyses of quantitative data from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs

Gain an unbiased perspective of the market and its potential.

• Market size and current treatment approaches
• What’s needed to support early adoption and optimization of an asset
• Unmet needs and attributes most desired in new therapeutics
• Expert opinions on the likely disruption introduced by pipeline agents

• Insights are based on analyses of quantitative data from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs

Gain an unbiased perspective of the market and its potential.

• Market size and current treatment approaches
• What’s needed to support early adoption and optimization of an asset
• Unmet needs and attributes most desired in new therapeutics
• Expert opinions on the likely disruption introduced by pipeline agents

• Insights are based on analyses of quantitative data from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs

Gain an unbiased perspective of the market and its potential.

• Market size and current treatment approaches
• What’s needed to support early adoption and optimization of an asset
• Unmet needs and attributes most desired in new therapeutics
• Expert opinions on the likely disruption introduced by pipeline agents

• Insights are based on analyses of quantitative data from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs